Risako Onodera Selected Research

Cyclodextrins

1/2022	Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice.
10/2021	Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death.
5/2019	In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease.
1/2019	In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
1/2019	Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
1/2015	Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
11/2014	Potential use of fucose-appended dendrimer/α-cyclodextrin conjugates as NF-κB decoy carriers for the treatment of lipopolysaccharide-induced fulminant hepatitis in mice.
10/2014	Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy.
12/2013	Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
4/2013	Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Risako Onodera Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 01/2013
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022 - 05/2019
2	Melanoma (Melanoma, Malignant) 01/2015 - 08/2013
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Leukemia 10/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2020
1	Neuroblastoma 05/2020
1	Hepatomegaly 05/2019
1	Amyloidosis 01/2019
1	Infections 05/2018
1	Virus Diseases (Viral Diseases) 05/2018
1	Human Influenza (Influenza) 01/2018
1	Choroidal Neovascularization 01/2017
1	Asthma (Bronchial Asthma) 05/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2016
1	Corneal Neovascularization 03/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Massive Hepatic Necrosis 11/2014
1	Carcinogenesis 03/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2013
1	Cholangiocarcinoma 08/2013
1	Hemolysis 10/2009

Drug/Important Bio-Agent (IBA)

12	CyclodextrinsIBA 01/2022 - 10/2009
9	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2013
7	Antineoplastic Agents (Antineoplastics)IBA 10/2021 - 01/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2009
4	Liposomes (Liposome)IBA 01/2022 - 01/2017
4	CholesterolIBA 01/2022 - 08/2013
4	Dendrimers (Dendrons)IBA 05/2020 - 11/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 01/2013
2	Drug CarriersIBA 01/2022 - 10/2014
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2019
1	SilymarinIBA 02/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Lactose FDA LinkGeneric 01/2022
1	GangliosidesIBA 01/2022
1	GlycolipidsIBA 01/2022
1	SphingomyelinsIBA 01/2022
1	Polyethylene (Polythene)IBA 05/2020
1	fluorescein isothiocyanate dextranIBA 05/2020
1	isothiocyanic acidIBA 05/2020
1	liposomal doxorubicin (Doxil)FDA Link 05/2020
1	Bromelains (Bromelain)IBA 05/2020
1	GelatinIBA 05/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2020
1	LipofectamineIBA 05/2020
1	Prealbumin (Transthyretin)IBA 01/2019
1	Polo-Like Kinase 1IBA 01/2019
1	stearylamineIBA 05/2018
1	VaccinesIBA 01/2018
1	Vaccine AdjuvantsIBA 01/2018
1	AntigensIBA 01/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018
1	CPG-oligonucleotideIBA 01/2018
1	Diclofenac (SR 38)FDA LinkGeneric 01/2017
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017
1	Procaterol (Pro-Air)IBA 05/2016
1	Angiopoietin-Like Protein 2IBA 03/2016
1	Lipid NanoparticlesIBA 03/2016
1	Janus Kinase 3IBA 01/2015
1	Recombinases (Recombinase)IBA 01/2015
1	Alanine Transaminase (SGPT)IBA 11/2014
1	FucoseIBA 11/2014
1	LipopolysaccharidesIBA 11/2014
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2014
1	hexanoic acid (hexanoate)IBA 12/2013
1	AcidsIBA 04/2013
1	CaproatesIBA 04/2013

Therapy/Procedure

5	Intravenous Administration 05/2020 - 01/2013
3	Therapeutics 01/2022 - 03/2014
3	Drug Therapy (Chemotherapy) 05/2016 - 10/2014
2	Intravenous Injections 11/2014 - 01/2013
1	Lasers (Laser) 01/2017